Cagrilintide 5mg — Vial Spec, Reconstitution Math & COA

1. Technical Overview of the Cagrilintide 5mg Research Specimen

A 5mg vial of Cagrilintide contains exactly 5.0 milligrams of lyophilized, synthetic acylated amylin analogue supplied as a purified white powder cake. This specific unit mass is frequently requested by academic, pharmaceutical, and biotechnology laboratories conducting multi-week rodent bioassays, receptor binding kinetics, or high-throughput microplate experiments where consistent stock solutions are required across multiple assay runs.

When purchasing from PX1 Research, researchers receive high-purity cagrilintide manufactured under stringent cGMP-compliant conditions. Every 5mg fill size is vacuum-sealed under inert argon gas within Type I borosilicate glass vials to prevent hydrolytic degradation and oxidative stress during long-term freezer storage. Laboratory teams selecting the 5mg mass format achieve optimal balance between reagent shelf-life and volumetric concentration flexibility for complex protocol workflows.

2. Molecular Mechanism and Comparative Class Analysis

Cagrilintide operates as a long-acting non-selective agonist of both the amylin receptors (AMYR: AMY1, AMY2, and AMY3) and the calcitonin receptor (CTR). By mimicking endogenous amylin, preclinical studies indicate that Cagrilintide induces intracellular cyclic adenosine monophosphate (cAMP) accumulation, modulating satiety signalling and gastric emptying velocity in rodent metabolic models.

In contemporary metabolic research, Cagrilintide is frequently evaluated alongside or in combination with incretin mimetics. While traditional GLP-1 receptor agonists such as semaglutide target the glucagon-like peptide-1 receptor exclusively, dual-action incretins like tirzepatide engage both GLP-1 and GIP signaling networks. Furthermore, multi-receptor compounds like retatrutide recruit glucagon receptors to drive energy expenditure. Cagrilintide provides a distinct, complementary mechanism by engaging the calcitonin/amylin receptor complex without direct activation of canonical incretin receptors.

3. Reconstitution Mathematics for 5mg Lyophilized Mass

Accurate volumetric reconstitution is essential for maintaining precision in cell culture treatments or micro-dosing protocols in preclinical animal subjects. Researchers reconstituting a 5mg vial must utilize sterile laboratory diluents, such as 0.9% Benzyl Alcohol Bacteriostatic Water or Sterile Normal Saline, based on the target assay requirements.

To achieve target working concentrations from a 5mg (5,000 micrograms) solid cake, utilize the following volumetric additions: • 1.0 mL Diluent Addition: Yields a concentration of 5.0 mg/mL (5,000 µg/mL or 50 µg per 10 µL). • 2.0 mL Diluent Addition: Yields a concentration of 2.5 mg/mL (2,500 µg/mL or 25 µg per 10 µL). • 3.0 mL Diluent Addition: Yields a concentration of 1.67 mg/mL (1,666.7 µg/mL or 16.67 µg per 10 µL). • 5.0 mL Diluent Addition: Yields a concentration of 1.0 mg/mL (1,000 µg/mL or 10 µg per 10 µL).

To quickly verify custom concentration target values based on variable solvent volumes, lab personnel should utilize our interactive reconstitution calculator tool before preparing stock solutions.

4. Laboratory Aliquoting and Volumetric Handling Protocols

Once solubilized, repeated freeze-thaw cycles of liquid peptide solutions can cause peptide aggregation, hydrophobic adsorption to glass/plastic walls, and structural cleavage of the peptide chain. To maximize compound integrity across extended research timelines, aliquoting the stock solution immediately after reconstitution is strongly recommended.

Reconstituted Cagrilintide should be divided into single-use micro-centrifuge tubes using low-binding polypropylene pipettes. Aliquots should be sized according to daily assay throughput requirements to eliminate the necessity of refreezing melted stock. When handling reconstituted solutions, gentle swiveling is advised; vigorous vortexing or mechanical agitations must be avoided to prevent protein shearing and foam formation.

5. Analytical Quality Control and Lot-Matched COA Verification

PX1 Research enforces rigid analytical quality control for every fill lot of Cagrilintide 5mg. Prior to release, independent ISO 17025 accredited laboratories analyze each batch to confirm purity, identity, chemical structure, and biological safety standards required for sensitive research environments.

Primary testing methods include High-Performance Liquid Chromatography (HPLC) to verify chemical purity (>99.0%), Mass Spectrometry (MS) to confirm exact molecular mass (matching the theoretical mass of 4414.0 Da), and the Limulus Amebocyte Lysate (LAL) assay to guarantee endotoxin levels remain strictly under <0.05 EU/mg. Investigators can access and download batch-specific certificates by visiting our dedicated certificate of analysis (COA) repository.

6. Thermal Stability, Reconstitution Solvents, and Storage Guidelines

The lyophilized peptide matrix of Cagrilintide exhibits high stability when stored under proper thermal conditions. Dry vials should be maintained at -20°C for short-to-medium duration storage (up to 12 months) or -80°C for long-term biobanking. Ambient exposure during shipping is tolerated due to high-purity freeze-drying techniques, though immediate refrigeration upon receipt is required.

Following reconstitution with bacteriostatic water, liquid stock solutions must be stored refrigerated between 2°C and 8°C and protected from light. Under refrigerated conditions, preserved liquid stock remains stable for up to 28 days. If unpreserved sterile water (WFI) is selected as the solvent due to sensitive cell line compatibility, the solution must be utilized within 24 hours or immediately frozen in single-use aliquots at -80°C.

7. Optimal Mass Selection: Comparing 5mg vs Alternative Fill Sizes

Determining whether the 5mg vial format suits your institutional protocol depends on the scale and duration of your investigation. Small-scale pilot assays or short-term in vitro binding screens often benefit from smaller unit masses to minimize waste, whereas high-density rodent cohorts or prolonged pharmacodynamic studies favor larger fill sizes.

For labs running continuous high-volume testing schedules, utilizing 5mg or larger mass formats reduces per-milligram reagent expense and minimizes lot-to-lot analytical variability. Institutional buyers seeking bulk procurement, routine standing shipments, or custom assay packaging can explore our all peptides catalog or register for dedicated institutional access via our wholesale lab account portal.

8. Preclinical Experimental Frameworks for In Vitro and In Vivo Models

Preclinical literature demonstrates that synthetic acylated amylin agonists like Cagrilintide display prolonged elimination half-lives in animal models relative to native amylin, primarily due to non-covalent albumin binding mediated by its fatty acid side-chain. In vitro cell assay frameworks frequently examine the activation of human AMY1, AMY2, AMY3, and CTR receptors transfected into CHO or HEK293 cell lines.

In vivo rodent models (such as diet-induced obese Sprague-Dawley rats or C57BL/6J mice) are routinely employed to measure post-prandial glycemic control, rate of gastric emptying, lipid oxidation parameters, and cumulative food intake. Researchers seeking expanded methodology background and published reference citations can review detailed entries in our research library hub.